METHODS INVOLVING PDGFRBETA INHIBITORS
Value Drivers by Geography
PCT Application Office Action Grant
Rest of the World
The invention refers to PDGFRbeta inhibitor for use in the antiproliferative treatment of T-cell lymphoma, in particular NHL, ALCL and PTCL.
A method of treating a patient with T-cell lymphoma and susceptible to a cell proliferative disorder comprising: obtaining a PDGFRbeta inhibitor; and administering the PDGFRbeta inhibitor to the patient.